---
layout: default
title: EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment
---

# EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2512.14019" class="toolbar-btn" target="_blank">üìÑ arXiv: 2512.14019v1</a>
  <a href="https://arxiv.org/pdf/2512.14019.pdf" class="toolbar-btn" target="_blank">üì• PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2512.14019v1" onclick="toggleFavorite(this, '2512.14019v1', 'EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment')" title="Ê∑ªÂä†Âà∞Êî∂ËóèÂ§π">‚òÜ Êî∂Ëóè</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">üîó ÂàÜ‰∫´</button>
</div>


**‰ΩúËÄÖ**: Juseung Yun, Sunwoo Yu, Sumin Ha, Jonghyun Kim, Janghyeon Lee, Jongseong Jang, Soonyoung Lee

**ÂàÜÁ±ª**: cs.LG, q-bio.QM

**ÂèëÂ∏ÉÊó•Êúü**: 2025-12-16

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

**EXAONE Path 2.5ÔºöÂ§öÁªÑÂ≠¶ÂØπÈΩêÁöÑÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåÁî®‰∫éÊõ¥ÂÖ®Èù¢ÁöÑËÇøÁò§ÁîüÁâ©Â≠¶ÁêÜËß£**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **ÊîØÊü±‰∫åÔºöRLÁÆóÊ≥ï‰∏éÊû∂ÊûÑ (RL & Architecture)** **ÊîØÊü±‰πùÔºöÂÖ∑Ë∫´Â§ßÊ®°Âûã (Embodied Foundation Models)**

**ÂÖ≥ÈîÆËØç**: `ÁóÖÁêÜÂ≠¶` `Â§öÊ®°ÊÄÅÂ≠¶‰π†` `ÁªÑÂ≠¶Êï∞ÊçÆ` `ËÇøÁò§ÁîüÁâ©Â≠¶` `ÂØπÊØîÂ≠¶‰π†` `‰ΩçÁΩÆÁºñÁ†Å` `Á≤æÂáÜËÇøÁò§Â≠¶`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. Áé∞ÊúâÁóÖÁêÜÂ≠¶Ê®°Âûã‰∏ªË¶Å‰æùËµñÂõæÂÉè‰ø°ÊÅØÔºåÂøΩÁï•‰∫ÜÂü∫Âõ†ÁªÑÂ≠¶Á≠âÂÖ∂‰ªñÁîüÁâ©Â±ÇÈù¢ÁöÑ‰ø°ÊÅØÔºåÈôêÂà∂‰∫ÜÂØπËÇøÁò§ÁîüÁâ©Â≠¶ÁöÑÂÖ®Èù¢ÁêÜËß£„ÄÇ
2. EXAONE Path 2.5ÈÄöËøáÂ§öÊ®°ÊÄÅËûçÂêàÔºåËÅîÂêàÂª∫Ê®°ÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑÂ≠¶„ÄÅË°®ËßÇÂü∫Âõ†ÁªÑÂ≠¶ÂíåËΩ¨ÂΩïÁªÑÂ≠¶Êï∞ÊçÆÔºåÊûÑÂª∫Êõ¥ÂÖ®Èù¢ÁöÑÊÇ£ËÄÖË°®ÂæÅ„ÄÇ
3. ËØ•Ê®°ÂûãÂú®Patho-Bench‰∏äËææÂà∞SOTAÊÄßËÉΩÔºåÂπ∂Âú®ÂÜÖÈÉ®‰∏¥Â∫äÊï∞ÊçÆÈõÜ‰∏äË°®Áé∞Âá∫Êõ¥È´òÁöÑÈÄÇÂ∫îÊÄßÔºåÈ™åËØÅ‰∫ÜÂ§öÊ®°ÊÄÅËûçÂêàÁöÑÊúâÊïàÊÄß„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

ÁôåÁóáËøõÂ±ïÊ∫ê‰∫éÂ§ö‰∏™ÁîüÁâ©Â±ÇÈù¢ÁöÑÁõ∏‰∫í‰ΩúÁî®ÔºåÁâπÂà´ÊòØÂΩ¢ÊÄÅÂ≠¶‰πãÂ§ñ‰ª•ÂèäÂõæÂÉèÊ®°ÂûãÊó†Ê≥ïÊçïÊçâÁöÑÂàÜÂ≠êÂ±ÇÈù¢„ÄÇ‰∏∫‰∫ÜÊçïÊçâÊõ¥ÂπøÊ≥õÁöÑÁîüÁâ©ÂõæÊôØÔºåÊàë‰ª¨ÊèêÂá∫‰∫ÜEXAONE Path 2.5Ôºå‰∏Ä‰∏™ÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°ÂûãÔºåÂÆÉËÅîÂêàÂª∫Ê®°ÁªÑÁªáÂ≠¶„ÄÅÂü∫Âõ†ÁªÑÂ≠¶„ÄÅË°®ËßÇÂü∫Âõ†ÁªÑÂ≠¶ÂíåËΩ¨ÂΩïÁªÑÂ≠¶Ê®°ÊÄÅÔºå‰∫ßÁîü‰∏Ä‰∏™ÁªºÂêàÁöÑÊÇ£ËÄÖË°®ÂæÅÔºåÊõ¥ÂÖ®Èù¢Âú∞ÂèçÊò†ËÇøÁò§ÁîüÁâ©Â≠¶„ÄÇÊàë‰ª¨ÁöÑÊñπÊ≥ïÂåÖÂê´‰∏â‰∏™ÂÖ≥ÈîÆÁªÑÊàêÈÉ®ÂàÜÔºöÔºà1ÔºâÂ§öÊ®°ÊÄÅSigLIPÊçüÂ§±ÔºåÊîØÊåÅË∑®ÂºÇÊûÑÊ®°ÊÄÅÁöÑÊâÄÊúâÊàêÂØπÂØπÊØîÂ≠¶‰π†ÔºõÔºà2ÔºâÁâáÊÆµÊÑüÁü•ÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†ÅÔºàF-RoPEÔºâÊ®°ÂùóÔºåÂú®WSI‰∏≠‰øùÁïôÁ©∫Èó¥ÁªìÊûÑÂíåÁªÑÁªáÁâáÊÆµÊãìÊâëÔºõÔºà3ÔºâWSIÂíåRNA-seqÁöÑÈ¢ÜÂüü‰∏ìÁî®ÂÜÖÈÉ®Âü∫Á°ÄÊ®°ÂûãÔºå‰∏∫Á®≥ÂÅ•ÁöÑÂ§öÊ®°ÊÄÅÂØπÈΩêÊèê‰æõÁîüÁâ©Â≠¶Âü∫Á°ÄÁöÑÂµåÂÖ•„ÄÇÊàë‰ª¨Âú®‰∏§‰∏™‰∫íË°•ÁöÑÂü∫ÂáÜ‰∏äËØÑ‰º∞‰∫ÜEXAONE Path 2.5Ôºå‰∏Ä‰∏™ÊòØÂÜÖÈÉ®ÁúüÂÆû‰∏¥Â∫äÊï∞ÊçÆÈõÜÔºåÂè¶‰∏Ä‰∏™ÊòØÊ∂µÁõñ80‰∏™‰ªªÂä°ÁöÑPatho-BenchÂü∫ÂáÜ„ÄÇÊàë‰ª¨ÁöÑÊ°ÜÊû∂Â±ïÁ§∫‰∫ÜÈ´òÊï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéáÔºåÂú®Patho-Bench‰∏äÂÆûÁé∞‰∫Ü‰∏éÊúÄÂÖàËøõÁöÑÂü∫Á°ÄÊ®°ÂûãÁõ∏ÂΩìÁöÑÊÄßËÉΩÔºåÂêåÊó∂Âú®ÂÜÖÈÉ®‰∏¥Â∫äÁéØÂ¢É‰∏≠Ë°®Áé∞Âá∫ÊúÄÈ´òÁöÑÈÄÇÂ∫îÊÄß„ÄÇËøô‰∫õÁªìÊûúÁ™ÅÂá∫‰∫ÜÁîüÁâ©‰ø°ÊÅØÂ§öÊ®°ÊÄÅËÆæËÆ°ÁöÑ‰ª∑ÂÄºÔºåÂπ∂Âº∫Ë∞É‰∫ÜÁî®‰∫é‰∏ã‰∏Ä‰ª£Á≤æÂáÜËÇøÁò§Â≠¶ÁöÑÊï¥ÂêàÂü∫Âõ†ÂûãÂà∞Ë°®ÂûãÂª∫Ê®°ÁöÑÊΩúÂäõ„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöÁé∞ÊúâÁóÖÁêÜÂ≠¶Âü∫Á°ÄÊ®°Âûã‰∏ªË¶Å‰æùËµñ‰∫éÁªÑÁªáÁóÖÁêÜÂ≠¶ÂõæÂÉèÔºåÂøΩÁï•‰∫ÜÂü∫Âõ†ÁªÑÂ≠¶„ÄÅË°®ËßÇÂü∫Âõ†ÁªÑÂ≠¶ÂíåËΩ¨ÂΩïÁªÑÂ≠¶Á≠âÂÖ∂‰ªñÈáçË¶ÅÁöÑÁîüÁâ©‰ø°ÊÅØ„ÄÇËøôÂØºËá¥Ê®°ÂûãÊó†Ê≥ïÂÖ®Èù¢ÁêÜËß£ËÇøÁò§ÁöÑÂ§çÊùÇÁîüÁâ©Â≠¶Êú∫Âà∂ÔºåÈôêÂà∂‰∫ÜÂÖ∂Âú®Á≤æÂáÜËÇøÁò§Â≠¶‰∏≠ÁöÑÂ∫îÁî®„ÄÇÁé∞ÊúâÊñπÊ≥ïÈöæ‰ª•ÊúâÊïàÂú∞Êï¥ÂêàËøô‰∫õÂºÇÊûÑÊï∞ÊçÆÔºåÂπ∂‰ªé‰∏≠Â≠¶‰π†Âà∞ÊúâÊÑè‰πâÁöÑÂÖ≥ËÅî„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöEXAONE Path 2.5ÁöÑÊ†∏ÂøÉÊÄùË∑ØÊòØÈÄöËøáÂ§öÊ®°ÊÄÅÂ≠¶‰π†ÔºåÂ∞ÜÁªÑÁªáÁóÖÁêÜÂ≠¶ÂõæÂÉè‰∏éÂü∫Âõ†ÁªÑÂ≠¶„ÄÅË°®ËßÇÂü∫Âõ†ÁªÑÂ≠¶ÂíåËΩ¨ÂΩïÁªÑÂ≠¶Êï∞ÊçÆËøõË°åÊúâÊïàÊï¥ÂêàÔºå‰ªéËÄåÊûÑÂª∫‰∏Ä‰∏™Êõ¥ÂÖ®Èù¢ÁöÑËÇøÁò§ÁîüÁâ©Â≠¶Ë°®ÂæÅ„ÄÇËøôÁßçÂ§öÊ®°ÊÄÅËûçÂêàËÉΩÂ§üÊçïÊçâ‰∏çÂêåÁîüÁâ©Â±ÇÈù¢ÁöÑÁõ∏‰∫í‰ΩúÁî®ÔºåÊè≠Á§∫ËÇøÁò§ËøõÂ±ïÁöÑÊΩúÂú®Êú∫Âà∂„ÄÇËøôÊ†∑ËÆæËÆ°ÁöÑÂéüÂõ†Âú®‰∫éÔºåÁôåÁóáÁöÑÂèëÁîüÂèëÂ±ïÊòØÂ§öÂõ†Á¥†ÂÖ±Âêå‰ΩúÁî®ÁöÑÁªìÊûúÔºåÂçï‰∏ÄÊ®°ÊÄÅÁöÑ‰ø°ÊÅØÊó†Ê≥ïÊèê‰æõÂÆåÊï¥ÁöÑÂõæÊôØ„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöEXAONE Path 2.5ÁöÑÊäÄÊúØÊ°ÜÊû∂‰∏ªË¶ÅÂåÖÂê´‰∏â‰∏™ÂÖ≥ÈîÆÊ®°ÂùóÔºö1) Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±ÔºöÁî®‰∫éË∑®ÂºÇÊûÑÊ®°ÊÄÅËøõË°åÊâÄÊúâÊàêÂØπÁöÑÂØπÊØîÂ≠¶‰π†Ôºå‰øÉËøõ‰∏çÂêåÊ®°ÊÄÅ‰πãÈó¥ÁöÑ‰ø°ÊÅØÂØπÈΩê„ÄÇ2) ÁâáÊÆµÊÑüÁü•ÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†ÅÔºàF-RoPEÔºâÔºöÁî®‰∫éÂú®ÂÖ®ÂàáÁâáÂõæÂÉèÔºàWSIÔºâ‰∏≠‰øùÁïôÁ©∫Èó¥ÁªìÊûÑÂíåÁªÑÁªáÁâáÊÆµÁöÑÊãìÊâëÂÖ≥Á≥ªÔºåÊèêÈ´òÊ®°ÂûãÂØπÁ©∫Èó¥‰ø°ÊÅØÁöÑÂà©Áî®ËÉΩÂäõ„ÄÇ3) È¢ÜÂüü‰∏ìÁî®ÂÜÖÈÉ®Âü∫Á°ÄÊ®°ÂûãÔºöÂàÜÂà´‰∏∫WSIÂíåRNA-seqËÆæËÆ°ÔºåÊèê‰æõÁîüÁâ©Â≠¶Âü∫Á°ÄÁöÑÂµåÂÖ•ÔºåÂ¢ûÂº∫Â§öÊ®°ÊÄÅÂØπÈΩêÁöÑÈ≤ÅÊ£íÊÄß„ÄÇÊï¥‰ΩìÊµÅÁ®ãÊòØÂÖàÂàÜÂà´ÂØπ‰∏çÂêåÊ®°ÊÄÅÁöÑÊï∞ÊçÆËøõË°åÈ¢ÑÂ§ÑÁêÜÂíåÁâπÂæÅÊèêÂèñÔºåÁÑ∂ÂêéÈÄöËøáÂ§öÊ®°ÊÄÅSigLIPÊçüÂ§±ËøõË°åÂØπÈΩêÂíåËûçÂêàÔºåÊúÄÁªàÂæóÂà∞‰∏Ä‰∏™ÁªºÂêàÁöÑÊÇ£ËÄÖË°®ÂæÅ„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöËØ•ËÆ∫ÊñáÁöÑÂÖ≥ÈîÆÂàõÊñ∞Âú®‰∫éÂ§öÊ®°ÊÄÅËûçÂêàÁ≠ñÁï•ÂíåF-RoPEÊ®°ÂùóÁöÑËÆæËÆ°„ÄÇÂ§öÊ®°ÊÄÅËûçÂêàÁ≠ñÁï•ÈÄöËøáSigLIPÊçüÂ§±ÂÆûÁé∞‰∫ÜË∑®ÂºÇÊûÑÊ®°ÊÄÅÁöÑÊúâÊïàÂØπÈΩêÔºåËÄåF-RoPEÊ®°ÂùóÂàôËÉΩÂ§üÊõ¥Â•ΩÂú∞‰øùÁïôWSI‰∏≠ÁöÑÁ©∫Èó¥‰ø°ÊÅØ„ÄÇ‰∏éÁé∞ÊúâÊñπÊ≥ïÁõ∏ÊØîÔºåEXAONE Path 2.5ËÉΩÂ§üÊõ¥ÂÖ®Èù¢Âú∞ÊçïÊçâËÇøÁò§ÁöÑÁîüÁâ©Â≠¶ÁâπÂæÅÔºåÂπ∂ÊèêÈ´òÊ®°ÂûãÂú®‰∏¥Â∫äÂ∫îÁî®‰∏≠ÁöÑÈÄÇÂ∫îÊÄß„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**ÔºöÂú®Â§öÊ®°ÊÄÅSigLIPÊçüÂ§±‰∏≠Ôºå‰ΩúËÄÖÈááÁî®‰∫ÜÂØπÊØîÂ≠¶‰π†ÁöÑÊñπÊ≥ïÔºåÈÄöËøáÊúÄÂ§ßÂåñÊ≠£Ê†∑Êú¨ÂØπ‰πãÈó¥ÁöÑÁõ∏‰ººÊÄßÔºåÊúÄÂ∞èÂåñË¥üÊ†∑Êú¨ÂØπ‰πãÈó¥ÁöÑÁõ∏‰ººÊÄßÔºå‰ªéËÄåÂÆûÁé∞‰∏çÂêåÊ®°ÊÄÅ‰πãÈó¥ÁöÑ‰ø°ÊÅØÂØπÈΩê„ÄÇF-RoPEÊ®°ÂùóÂàôÈÄöËøáÂºïÂÖ•ÊóãËΩ¨‰ΩçÁΩÆÁºñÁ†ÅÔºåËÉΩÂ§üÊõ¥Â•ΩÂú∞‰øùÁïôWSI‰∏≠ÁöÑÁ©∫Èó¥ÁªìÊûÑÂíåÁªÑÁªáÁâáÊÆµÁöÑÊãìÊâëÂÖ≥Á≥ª„ÄÇÊ≠§Â§ñÔºå‰ΩúËÄÖËøòÈíàÂØπWSIÂíåRNA-seqËÆæËÆ°‰∫ÜÈ¢ÜÂüü‰∏ìÁî®ÁöÑÂÜÖÈÉ®Âü∫Á°ÄÊ®°ÂûãÔºå‰ª•Êèê‰æõÁîüÁâ©Â≠¶Âü∫Á°ÄÁöÑÂµåÂÖ•„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

EXAONE Path 2.5Âú®Patho-BenchÂü∫ÂáÜÊµãËØï‰∏≠ËææÂà∞‰∫Ü‰∏éÊúÄÂÖàËøõÁöÑÂü∫Á°ÄÊ®°ÂûãÁõ∏ÂΩìÁöÑÊÄßËÉΩÔºåÂêåÊó∂Âú®ÂÜÖÈÉ®‰∏¥Â∫äÊï∞ÊçÆÈõÜ‰∏äË°®Áé∞Âá∫Êõ¥È´òÁöÑÈÄÇÂ∫îÊÄß„ÄÇËøôË°®ÊòéËØ•Ê®°ÂûãÂú®ÂÆûÈôÖ‰∏¥Â∫äÂ∫îÁî®‰∏≠ÂÖ∑ÊúâÊõ¥Âº∫ÁöÑÊ≥õÂåñËÉΩÂäõÂíåÈ≤ÅÊ£íÊÄß„ÄÇÊ≠§Â§ñÔºåËØ•Ê®°ÂûãËøòÂÖ∑ÊúâÈ´òÊï∞ÊçÆÂíåÂèÇÊï∞ÊïàÁéáÔºåËÉΩÂ§üÂú®ÊúâÈôêÁöÑÊï∞ÊçÆÈõÜ‰∏äÂèñÂæóËâØÂ•ΩÁöÑÊÄßËÉΩ„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

EXAONE Path 2.5Âú®Á≤æÂáÜËÇøÁò§Â≠¶È¢ÜÂüüÂÖ∑ÊúâÂπøÊ≥õÁöÑÂ∫îÁî®ÂâçÊôØÔºåÂèØÁî®‰∫éÁôåÁóáËØäÊñ≠„ÄÅÈ¢ÑÂêéÈ¢ÑÊµã„ÄÅÊ≤ªÁñóÊñπÊ°àÈÄâÊã©ÂíåËçØÁâ©Á†îÂèë„ÄÇÈÄöËøáÊï¥ÂêàÂ§öÁªÑÂ≠¶Êï∞ÊçÆÔºåËØ•Ê®°ÂûãËÉΩÂ§üÊõ¥ÂÖ®Èù¢Âú∞ÁêÜËß£ËÇøÁò§ÁöÑÁîüÁâ©Â≠¶ÁâπÂæÅÔºå‰ªéËÄå‰∏∫‰∏¥Â∫äÂÜ≥Á≠ñÊèê‰æõÊõ¥ÂáÜÁ°ÆÁöÑ‰æùÊçÆ„ÄÇÊú™Êù•ÔºåËØ•Ê®°ÂûãÊúâÊúõÂ∫îÁî®‰∫é‰∏™ÊÄßÂåñÊ≤ªÁñóÊñπÊ°àÁöÑÂà∂ÂÆöÔºåÊèêÈ´òÁôåÁóáÊ≤ªÁñóÁöÑÊúâÊïàÊÄßÂíåÊÇ£ËÄÖÁöÑÁîüÂ≠òÁéá„ÄÇ

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Cancer progression arises from interactions across multiple biological layers, especially beyond morphological and across molecular layers that remain invisible to image-only models. To capture this broader biological landscape, we present EXAONE Path 2.5, a pathology foundation model that jointly models histologic, genomic, epigenetic and transcriptomic modalities, producing an integrated patient representation that reflects tumor biology more comprehensively. Our approach incorporates three key components: (1) multimodal SigLIP loss enabling all-pairwise contrastive learning across heterogeneous modalities, (2) a fragment-aware rotary positional encoding (F-RoPE) module that preserves spatial structure and tissue-fragment topology in WSI, and (3) domain-specialized internal foundation models for both WSI and RNA-seq to provide biologically grounded embeddings for robust multimodal alignment. We evaluate EXAONE Path 2.5 against six leading pathology foundation models across two complementary benchmarks: an internal real-world clinical dataset and the Patho-Bench benchmark covering 80 tasks. Our framework demonstrates high data and parameter efficiency, achieving on-par performance with state-of-the-art foundation models on Patho-Bench while exhibiting the highest adaptability in the internal clinical setting. These results highlight the value of biologically informed multimodal design and underscore the potential of integrated genotype-to-phenotype modeling for next-generation precision oncology.

